{{Cite journal| doi = 10.1001/jamacardio.2021.0669| issn = 2380-6591 (Electronic) 2380-6583 (Print)| volume = 6| issue = 7| pages = 771–780| last1 = Nestelberger| first1 = T.| last2 = Boeddinghaus| first2 = J.| last3 = Lopez-Ayala| first3 = P.| last4 = Kaier| first4 = T. E.| last5 = Marber| first5 = M.| last6 = Gysin| first6 = V.| last7 = Koechlin| first7 = L.| last8 = Sanchez| first8 = A. Y.| last9 = Gimenez| first9 = M. R.| last10 = Wussler| first10 = D.| last11 = Walter| first11 = J. E.| last12 = Strebel| first12 = I.| last13 = Zimmermann| first13 = T.| last14 = Glarner| first14 = N.| last15 = Miro| first15 = O.| last16 = Martin-Sanchez| first16 = F. J.| last17 = Zehnder| first17 = T.| last18 = Twerenbold| first18 = R.| last19 = Keller| first19 = D. I.| last20 = Mueller| first20 = C.| last21 = Investigators| first21 = Apace| title = Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial Infarction| journal = JAMA Cardiol| date = 2021-04-22| pmid = 33881449}}